Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 45,938
  • Shares Outstanding, K 4,678
  • Annual Sales, $ 5,390 K
  • Annual Income, $ -8,620 K
  • 60-Month Beta 0.81
  • Price/Sales 8.82
  • Price/Cash Flow N/A
  • Price/Book 4.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +768,561.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.82 +67.01%
on 04/30/20
16.39 -40.70%
on 05/14/20
+3.53 (+57.03%)
since 04/29/20
3-Month
2.52 +285.71%
on 03/16/20
16.39 -40.70%
on 05/14/20
+5.73 (+143.61%)
since 02/28/20
52-Week
2.52 +285.71%
on 03/16/20
26.80 -63.73%
on 06/14/19
-11.88 (-55.00%)
since 05/29/19

Most Recent Stories

More News
Applied DNA to Participate in Maxim Group's COVID-19 Virtual Conference Series on May 27

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based...

APDN : 9.72 (-1.02%)
Thinking about buying stock in Arbutus Biopharma, Dynavax Technologies, Applied DNA Sciences, Evoke Pharma, or Aphria?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABUS, DVAX, APDN, EVOK, and APHA.

APHA : 4.23 (-1.86%)
APDN : 9.72 (-1.02%)
ABUS : 2.17 (+0.46%)
DVAX : 6.12 (+26.45%)
EVOK : 2.47 (-1.98%)
Corporate News for May 15, 2020

Companies In The News Are: APDN, CSCO, IMUX, VRTU

CSCO : 47.82 (+4.88%)
APDN : 9.72 (-1.02%)
VRTU : 30.07 (+0.74%)
IMUX : 11.99 (+10.61%)
Applied DNA Sciences: Fiscal 2Q Earnings Snapshot

STONY BROOK, N.Y. (AP) _ Applied DNA Sciences Inc. (APDN) on Thursday reported a loss of $3 million in its fiscal second quarter.

APDN : 9.72 (-1.02%)
Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company") a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based...

APDN : 9.72 (-1.02%)
Technological Advances in the Anti-Viral Drug Therapy Market to Aid Treatment of COVID-19 Patients, Reports TBRC

, /PRNewswire/ -- Companies in the anti-viral drug therapy market are continuously innovating through technological advances to develop drugs to treat different viral infections. Biopharmaceutical companies...

APDN : 9.72 (-1.02%)
Thinking about buying stock in Applied DNA Sciences, Novus Therapeutics, Riot Blockchain, Upwork, or Delta Air Lines?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, NVUS, RIOT, UPWK, and DAL.

APDN : 9.72 (-1.02%)
DAL : 25.21 (-1.75%)
NVUS : 1.2700 (-3.05%)
RIOT : 2.14 (-3.17%)
UPWK : 12.44 (+3.75%)
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit

Applied DNA Sciences Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company," "our") announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the...

APDN : 9.72 (-1.02%)
Thinking about buying stock in Applied DNA Sciences, Viacom CBS, Southwest Airlines, Inuvo Inc, or SmileDirectClub?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APDN, VIAC, LUV, INUV, and SDC.

APDN : 9.72 (-1.02%)
INUV : 0.4300 (unch)
LUV : 32.10 (-1.38%)
VIAC : 20.74 (-2.17%)
Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET

Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2020 second quarter ended March 31, 2020 after market close on Thursday, May 14, 2020. In...

APDN : 9.72 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade APDN with:

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

2nd Resistance Point 10.12
1st Resistance Point 9.92
Last Price 9.72
1st Support Level 9.36
2nd Support Level 9.00

See More

52-Week High 26.80
Fibonacci 61.8% 17.53
Fibonacci 50% 14.66
Fibonacci 38.2% 11.79
Last Price 9.72
52-Week Low 2.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar